Join this session to become familiar with the rapidly changing field of GH treatment, particularly with regard to the move to promoting patient adherence and improving quality of life through the use of long-acting GH molecules.
During this talk, we will:
1) Review the long-acting GH molecules currently being tested
2) Give an overview of the phase 3 trial results available for pediatric and adult patients with GH deficiency
3) Discuss issues of safety, tolerability and efficacy in regard to who to put on long-acting GH
4) Identify what patients could benefit the most from receiving long-acting GH
*This activity is supported by an unrestricted educational grant from Pfizer.